EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Co‐Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia—Diagnostic and Perioperative Management Challenges

He Zheng iD, Qingsong Wang iD, Mingpu Wang iD, Shu Luo iD, Yuzhen Ma iD, Zhengqiang Wan iD

Cancer Reports · 2026-03 · 9 (3)

DOI: 10.1002/cnr2.70512 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Reports, online erschienen am 06.03.2026. Verfasst von He Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Suining First People's Hospital, Suining, Sichuan, China. Hauptthemen laut MEDLINE: Afibrinogenemia, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suining Health Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Congenital dysfibrinogenemia (CD), a rare autosomal dominant coagulation disorder, poses significant perioperative challenges in oncologic surgery due to hypofibrinogenemia and variable bleeding‐thrombosis risks. Case A 67‐year‐old woman presented with a 2.9 × 1.4 cm spiculated mass in the right middle lobe (RML) and persistent hypofibrinogenemia (0.56–0.58 g/L). Despite conventional fresh frozen plasma and cryoprecipitate transfusions, fibrinogen levels remained critically low. Preoperative optimization with human fibrinogen concentrates (total 4.0 g) normalized levels to 1.76 g/L within 24 h, enabling video‐assisted thoracoscopic (VATS) RML lobectomy with systematic lymphadenectomy (pT1cN0M0, Stage IA3). Postoperatively, fibrinogen gradually declined to 0.68 g/L at 1‐month follow‐up, necessitating extended surveillance. Genetic testing identified a heterozygous FGA c.103C>T (Arg35Cys) mutation, confirming CD diagnosis and thrombotic risk.

Conclusion

This case establishes three paradigms: (1) Mandatory comprehensive coagulation profiling in pulmonary resection candidates to identify CD; (2) superiority of fibrinogen concentrate over plasma‐derived products for rapid, sustained hemostasis in CD; (3) individualized thromboprophylaxis balancing hemorrhagic‐thrombotic risks through genetic risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AfibrinogenemiaLung NeoplasmsAdenocarcinoma of LungHumansFemaleAgedFibrinogenPneumonectomyPerioperative CareThoracic Surgery, Video-AssistedLymph Node Excision

Stichwörter der Autor:innen

congenital dysfibrinogenemiafibrinogen replacement therapylung adenocarcinomaminimally invasive thoracic surgeryperioperative coagulation management

Substanzen

FibrinogenFGA protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Suining First People's Hospital, Suining, Sichuan, China.
  • Oncology, Suining First People's Hospital, Suining, Sichuan, China.
  • Department of Oral and Maxillofacial Surgery, Suining First People's Hospital, Suining, Sichuan, China.

ORCID-Profile: He Zheng, Qingsong Wang, Mingpu Wang, Shu Luo, Yuzhen Ma, Zhengqiang Wan

Förderung

  • Suining Health Science and Technology Project

Zitieren

APA

Zheng, H., Wang, Q., Wang, M., Luo, S., Ma, Y., & Wan, Z. (2026). Case Report: Co‐Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia—Diagnostic and Perioperative Management Challenges. Cancer Reports, 9(3). https://doi.org/10.1002/cnr2.70512

Vancouver

Zheng H, Wang Q, Wang M, Luo S, Ma Y, Wan Z. Case Report: Co‐Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia—Diagnostic and Perioperative Management Challenges. Cancer Reports. 2026;9(3). doi:10.1002/cnr2.70512

BibTeX
@article{Zheng2026,
  author = {Zheng, He and Wang, Qingsong and Wang, Mingpu and Luo, Shu and Ma, Yuzhen and Wan, Zhengqiang},
  title = {Case Report: Co‐Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia—Diagnostic and Perioperative Management Challenges},
  journal = {Cancer Reports},
  year = {2026},
  volume = {9},
  number = {3},
  doi = {10.1002/cnr2.70512}
}
Kostenlos starten →